Dr Reddy's Launches Melphalam Hydrochloride Inj in USA | CORPORATE ETHOS

Dr Reddy’s Launches Melphalam Hydrochloride Inj in USA

By: | December 26, 2017
Dr Reddy's

Dec 26: Hyderabad-based drug maker Dr Reddy’s Laboratories Ltd on Tuesday said that it has launched its Melphalan Hydrochloride for Injection, a therapeutic equivalent generic version of Alkeran (melphalan Hydrochloride) for injection in the United States market, approved by the US Food and Drug Administration (USFDA).

“Dr Reddy’s Melphalan Hydrochloride for injection is available in a carton containing one-single dose clear glass vial of freeze-dried melphalan hydrochloride equivalent to 50 mg melphalan and one 10 ml clear glass vial of sterile diluent),” the company said.

The Alkeran brand and generic had US sales of approximately $107 million MAT for the most recent twelve months ending in October 2017 according to IMS Health.

Dr Reddy’s shares were trading at Rs 2,360.25, up 1.17% from the previous closing of Rs 2,333.05, on BSE at 3.47 pm today.